Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rea, H. H.
Right arrow Articles by Kolbe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rea, H. H.
Right arrow Articles by Kolbe, J.
(Chest. 1996;110:1446-1451.)
© 1996 American College of Chest Physicians

The Association Between Asthma Drugs and Severe Life-Threatening Attacks

Harold H. Rea MD1; Jeffrey E. Garrett MBChB1; Stephan F. Lanes PhD2; Brenda M. Birmann 2; and John Kolbe MBBS1

1 From the Respiratory Services, Green Lane Hospital, Auckland, New Zealand
2 From the Epidemiology Resources Inc, the New England Epidemiology Institute, Newton Lower Falls, Mass.

Objectives: To measure the association between asthma drugs and death or ICU admission due to asthma (severe life-threating attack of asthma [SLTA]), and to assess the possibility that these associations may not be causal but due to the prescription of these drugs to patients with more severe disease (confounding).

Design: Retrospective cohort study of 655 asthmatics who attended an emergency department in 1986 to 1987 followed till death or May 1989.

Methods: Outcome events were death or ICU admission due to asthma (SLTA). All hospital attendances were identified and patients classified at each according to drug exposure and a wide variety of measures of asthma severity. Incidence rates were computed as total outcome events divided by person-time contributed for each subject classified according to drug use and asthma severity. Rate ratio (RR) estimates for severe asthma outcomes associated with use as compared to nonuse of asthma drugs were calculated. Severity markers were identified and used to adjust the crude RR estimates.

Results: One hundred five SLTAs (15 deaths, 90 ICU admissions) occurred in 66 patients. Like inhaled fenoterol, oral β-agonists, theophylline, cromolyn, inhaled steroids, and oral steroids were all associated with an increased risk of SLTA. When adjusted progressively for measures of severity, these increased risks became insignificant except for cromolyn.

Conclusion: Unadjusted RR estimates for severe asthma events comparing exposure to a particular drug with nonuse are overestimates due to confounding. Control with two severity markers (hospital admission in the last year, use of oral corticosteroid at the time of previous admission) removes some confounding but control for additional severity markers not available in previous studies reduces the effect estimates further. These results suggest that the problem of confounding is substantial in nonrandomized epidemiologic studies of asthma drugs. Previous studies reporting RR estimates are likely to be confounded.

Key Words: adverse effects • asthma • drugs • retrospective studies

Submitted on November 29, 1995
Accepted on August 6, 2007




This article has been cited by other articles:


Home page
ChestHome page
C. S. Calfee, P. P. Katz, E. H. Yelin, C. Iribarren, and M. D. Eisner
The influence of perceived control of asthma on health outcomes.
Chest, November 1, 2006; 130(5): 1312 - 1318.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
L van der Merwe, A de Klerk, M Kidd, P G Bardin, and E M van Schalkwyk
Case-control study of severe life threatening asthma (SLTA) in a developing community.
Thorax, September 1, 2006; 61(9): 756 - 760.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
A. H. Anis, L. D. Lynd, X.-h. Wang, G. King, J. J. Spinelli, M. Fitzgerald, T. Bai, and P. Pare
Double trouble: impact of inappropriate use of asthma medication on the use of health care resources
Can. Med. Assoc. J., March 1, 2001; 164(5): 625 - 631.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.D. Eisner, T.A. Lieu, F. Chi, A.M. Capra, G.R. Mendoza, J.V. Selby, and P.D. Blanc
Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma
Eur. Respir. J., February 1, 2001; 17(2): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Kolbe, W Fergusson, M Vamos, and J Garrett
Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack
Thorax, December 1, 2000; 55(12): 1007 - 1015.
[Abstract] [Full Text]


Home page
BMJHome page
M. Sexton, M. D Althuis, N. Santanello, S. Hyndman, R. Williams, and D. Schmeidler
Sex differences in the use of asthma drugs: cross sectional study
BMJ, November 21, 1998; 317(7170): 1434 - 1437.
[Abstract] [Full Text]


Home page
ThoraxHome page
J Kolbe, W Fergusson, and J Garrett
Rapid onset asthma: a severe but uncommon manifestation
Thorax, April 1, 1998; 53(4): 241 - 247.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Chest Physicians.